Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.
<h4>Background</h4>Over the past several years, there have been several changes affecting the available options for oral HIV preexposure prophylaxis, including approvals for tenofovir alafenamide with emtricitabine in 2019 and a generic formulation of tenofovir disoproxil fumarate with e...
Saved in:
| Main Authors: | Elisabeth Merchant, Patricia Solleveld, Kevin Gibas, Douglas Krakower |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0311591 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal Outcomes Over the Course of 5 Years of Oral HIV Preexposure Prophylaxis Using Tenofovir Disoproxil/Emtricitabine
by: Dita C. Bolluyt, et al.
Published: (2025-06-01) -
Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
by: David C. Knox, et al.
Published: (2022-01-01) -
Linking Criminal Justice-Involved Individuals to HIV Preexposure Prophylaxis: A Qualitative Analysis of Multiple Stakeholder Perspectives
by: Jessica Lee MPH, et al.
Published: (2025-05-01) -
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01) -
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV
by: Eric S. Daar, et al.
Published: (2025-04-01)